Antu Eapan Thomas
Stock Analyst at Geojit Research
(1.08)
# 3,868
Out of 4,698 analysts
44
Total ratings
48.7%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by Antu Eapan Thomas
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: MANKIND Mankind Pharma Limited | Maintained: Buy | ₹2,660 | ₹2,328 | +14.27% | 1 | Jun 16, 2026 | |
| NSE: FORTIS Fortis Healthcare Limited | Reiterated: Buy | ₹1,150 | ₹905.00 | +27.07% | 1 | Jun 15, 2026 | |
| NSE: PVRINOX PVR INOX Limited | Maintained: Buy | ₹1,065 → ₹1,189 | ₹1,227 | -3.11% | 2 | Jun 5, 2026 | |
| NSE: RAINBOW Rainbow Children's Medicare Limited | Initiated Coverage: Buy | ₹1,679 | ₹1,447 | +16.02% | 1 | May 27, 2026 | |
| NSE: SBICARD SBI Cards and Payment Services Limited | Maintained: Buy | ₹950.00 → ₹698.00 | ₹658.25 | +6.04% | 2 | May 18, 2026 | |
| NSE: LICI Life Insurance Corporation of India | Reiterated: Buy | ₹544.00 → ₹467.00 | ₹415.35 | +12.44% | 3 | Mar 18, 2026 | |
| NSE: NBCC NBCC (India) Limited | Rated: Hold | n/a | $86.60 | - | 1 | Mar 17, 2026 | |
| NSE: GODREJPROP Godrej Properties Limited | Maintained: Buy | ₹2,096 | ₹1,982 | +5.75% | 1 | Feb 26, 2026 | |
| NSE: AMBER Amber Enterprises India Limited | Initiated Coverage: Buy | ₹9,156 | ₹7,474 | +22.50% | 1 | Feb 23, 2026 | |
| NSE: HCG HealthCare Global Enterprises Limited | Upgraded: Buy | ₹628.00 → ₹724.00 | ₹700.20 | +3.40% | 2 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹780.00 | ₹762.00 | +2.36% | 1 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,180 | ₹984.80 | +19.82% | 1 | Feb 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹568.00 → ₹791.00 | ₹272.10 | +190.70% | 3 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹686.00 | ₹562.30 | +22.00% | 1 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹4,409 → ₹4,560 | ₹3,964 | +15.03% | 2 | Feb 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹857.00 → ₹828.00 | ₹546.40 | +51.54% | 4 | Jan 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,244 → ₹2,080 | ₹1,510 | +37.75% | 2 | Jan 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹312.00 → ₹439.00 | ₹397.40 | +10.47% | 2 | Jan 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | ₹1,076 | ₹1,016 | +5.90% | 1 | Jan 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,085 | ₹1,060 | +2.40% | 1 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹2,254 | ₹1,775 | +26.99% | 1 | Nov 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,790 → ₹1,613 | ₹1,597 | +1.01% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹1,015 | ₹807.40 | +25.71% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | ₹1,820 | ₹1,264 | +44.01% | 1 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,791 → ₹1,247 | ₹482.00 | +158.71% | 2 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹3,691 | ₹2,304 | n/a | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | ₹386.00 | ₹183.11 | n/a | 1 | Jun 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹2,770 | ₹907.85 | n/a | 1 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | ₹326.00 | ₹315.70 | n/a | 1 | Dec 10, 2024 |
Mankind Pharma Limited
Jun 16, 2026
Maintained: Buy
Price Target: ₹2,660
Current: ₹2,328
Upside: +14.27%
Fortis Healthcare Limited
Jun 15, 2026
Reiterated: Buy
Price Target: ₹1,150
Current: ₹905.00
Upside: +27.07%
PVR INOX Limited
Jun 5, 2026
Maintained: Buy
Price Target: ₹1,065 → ₹1,189
Current: ₹1,227
Upside: -3.11%
Rainbow Children's Medicare Limited
May 27, 2026
Initiated Coverage: Buy
Price Target: ₹1,679
Current: ₹1,447
Upside: +16.02%
SBI Cards and Payment Services Limited
May 18, 2026
Maintained: Buy
Price Target: ₹950.00 → ₹698.00
Current: ₹658.25
Upside: +6.04%
Life Insurance Corporation of India
Mar 18, 2026
Reiterated: Buy
Price Target: ₹544.00 → ₹467.00
Current: ₹415.35
Upside: +12.44%
NBCC (India) Limited
Mar 17, 2026
Rated: Hold
Price Target: n/a
Current: $86.60
Upside: -
Godrej Properties Limited
Feb 26, 2026
Maintained: Buy
Price Target: ₹2,096
Current: ₹1,982
Upside: +5.75%
Amber Enterprises India Limited
Feb 23, 2026
Initiated Coverage: Buy
Price Target: ₹9,156
Current: ₹7,474
Upside: +22.50%
HealthCare Global Enterprises Limited
Feb 19, 2026
Upgraded: Buy
Price Target: ₹628.00 → ₹724.00
Current: ₹700.20
Upside: +3.40%
Feb 19, 2026
Maintained: Buy
Price Target: ₹780.00
Current: ₹762.00
Upside: +2.36%
Feb 16, 2026
Upgraded: Buy
Price Target: ₹1,180
Current: ₹984.80
Upside: +19.82%
Feb 11, 2026
Reiterated: Buy
Price Target: ₹568.00 → ₹791.00
Current: ₹272.10
Upside: +190.70%
Feb 10, 2026
Maintained: Buy
Price Target: ₹686.00
Current: ₹562.30
Upside: +22.00%
Feb 1, 2026
Reiterated: Buy
Price Target: ₹4,409 → ₹4,560
Current: ₹3,964
Upside: +15.03%
Jan 29, 2026
Reiterated: Buy
Price Target: ₹857.00 → ₹828.00
Current: ₹546.40
Upside: +51.54%
Jan 28, 2026
Maintained: Buy
Price Target: ₹2,244 → ₹2,080
Current: ₹1,510
Upside: +37.75%
Jan 2, 2026
Upgraded: Buy
Price Target: ₹312.00 → ₹439.00
Current: ₹397.40
Upside: +10.47%
Jan 1, 2026
Downgraded: Hold
Price Target: ₹1,076
Current: ₹1,016
Upside: +5.90%
Nov 11, 2025
Upgraded: Buy
Price Target: ₹1,085
Current: ₹1,060
Upside: +2.40%
Nov 10, 2025
Maintained: Buy
Price Target: ₹2,254
Current: ₹1,775
Upside: +26.99%
Nov 7, 2025
Maintained: Buy
Price Target: ₹1,790 → ₹1,613
Current: ₹1,597
Upside: +1.01%
Oct 31, 2025
Maintained: Buy
Price Target: ₹1,015
Current: ₹807.40
Upside: +25.71%
Oct 31, 2025
Upgraded: Buy
Price Target: ₹1,820
Current: ₹1,264
Upside: +44.01%
Oct 8, 2025
Reiterated: Buy
Price Target: ₹1,791 → ₹1,247
Current: ₹482.00
Upside: +158.71%
Jul 15, 2025
Reiterated: Buy
Price Target: ₹3,691
Current: ₹2,304
Upside: n/a
Jun 9, 2025
Maintained: Buy
Price Target: ₹386.00
Current: ₹183.11
Upside: n/a
Apr 2, 2025
Maintained: Hold
Price Target: ₹2,770
Current: ₹907.85
Upside: n/a
Dec 10, 2024
Maintained: Hold
Price Target: ₹326.00
Current: ₹315.70
Upside: n/a